More articles from Oncology: Clinical Diagnosis: Sarcoma/Melanoma

You have access
Assessment of early response to neoadjuvant chemotherapy in osteosarcoma using parallely installed PET/CT-MRI: Prospective study
Eun Young Park, Ilhan Lim, Byung Il Kim, Jae-Soo Koh, Chang-Bae Kong, Soo Yong Lee, Chang Woon Choi and Sang Moo Lim

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1920;
You have access
FDG PET/CT of patients with melanoma: Clinical impact of imaging the lower extremities
Tejvir Bawa, Aaron Jessop, Eric Rohren and Dominique Delbeke

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1918;
You have access
Is there a correlation between tumor proliferative activity and the FDG phenotype in pediatric sarcomas?
Franziska Walter, Noah Federman, Wipapat Apichairuk, Michael Phelps and Johannes Czernin

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 1919;
You have access
Metabolic activity measured on PET CT correlates with clinical outcomes in patients with limb and girdle sarcomas
Sonia Skamene, David Roberge, Robert Turcotte, Rajan Rakheja, Mathieu Charest, Marc Hickeson and Carolyn Freeman

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 593;
You have access
A prospective open label phase 3 trial of receptor-targeted 99mTc-tilmanocept for sentinel node evaluation in breast cancer and melanoma
Vernon Sondak and Anne Wallace

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 599;
You have access
Metabolic response by FDG-PET correlates with exon11 KIT mutation in patients with mucosal or acral melanoma or melanoma arising on chronically sun damaged skin treated with imatinib in a phase II trial
K. Zukotynski, Jeffrey Yap, Anita Giobbie-Hurder, Jeffrey Weber, R. Gonzalez, T. Gajewski, Steven O'Day, Kevin Kim, S. Hodi and Annick Van Den Abbeele

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 597;
You have access
Liver and mediastinum SUV in F-18 FDG PET/CT: Impact of immunotherapy
Abdullah Almardoof, Mustafa Altinyay, Waseem Touma, Nghi Nguyen and Medhat Osman

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 598;
You have access
The role of F-18 FDG PET/CT to predict prognosis of patients with osteosarcoma
Joon Yeun Park, Ilhan Lim, Chang-Bae Kong, Won Seok Song, Wan hyeong Cho, Dae Geun Jeon, Soo Yong Lee, Byung Il Kim, Chang Woon Choi and Sang Moo Lim

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 594;
You have access
Thallium-201 scintigraphy for evaluation of long-term prognosis in patients with osteosarcoma
Anri Inaki, Hiroshi Wakabayashi, Junichi Taki, Hisashi Sumiya, Hiroyuki Tsuchiya and Seigo Kinuya

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 596;
You have access
Metabolic activity measured by SUV from FDG-PET scans as a predictor of histopathologic characteristics: A retrospective review of 136 patients with sarcoma
Rajan Rakheja, Ayoub Nahal, Mathieu Charest, Fadi Brimo, Sonia Skamene, Laurent Azoulay, Jonathan Assayag and Marc Hickeson

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 595;

Main menu

User menu

Search

More articles from Oncology: Clinical Diagnosis: Sarcoma/Melanoma